Page 4,637«..1020..4,6364,6374,6384,639..4,6504,660..»

Silver Golub & Teitell LLP Sponsors BIAC Annual Conference on Brain Injury

Posted: Published on February 5th, 2014

STAMFORD, CT (PRWEB) February 05, 2014 While the controversy over the eventual outcome of the NFL concussion lawsuit continues post-Super Bowl, the Brain Injury Alliance of Connecticut (BIAC) will hold its annual conference on traumatic brain injury (TBI) at the Hilton Hartford, 315 Trumbull St., Hartford, CT, on March 7. Silver Golub & Teitell LLP is the presenting sponsor of the conference. The NFL lawsuit has raised the visibility of concussions dramatically in the mind of the general public, but we have been very aware of the importance of treatment, education and sharing information about brain injuries for many years, said Paul A. Slager, a partner at the Stamford trial law firm of Silver Golub & Teitell LLP and former president of the BIAC. We are delighted to once again support this very important conference and the work of the BIAC in raising awareness of both the prevention and treatment of brain injuries. The BIAC annual conference brings together hundreds of medical professionals, educators and service providers who will experience a full day of compelling discussion and education about brain injuries. Keynote speaker John D. Corrigan, Ph.D., Professor of Physical Medicine and Rehabilitation, Ohio State University, will discuss Epidemiology and … Continue reading →

Posted in Brain Injury Treatment | Comments Off on Silver Golub & Teitell LLP Sponsors BIAC Annual Conference on Brain Injury

New research: Blast injury predicts PTSD

Posted: Published on February 5th, 2014

Dr. Dewleen Baker, lead investigator for Marine Resiliency Study at La Jolla VA stands next to the startle room. The room is used to measure the startled response to a visual as well as audiotory response. Why do some U.S. combat veterans get debilitating emotional scars and others simply dont? How come people with even mild blast injuries complain about chronic headaches and back pain? Early results from a four-year study of Camp Pendleton Marines reveal that the strongest predictor of post-traumatic stress disorder or PTSD, the shell shock acknowledged after World War I is a blast injury to the brain. Its the first research to determine that brain trauma increases the risk of getting the psychological disorder, according to the lead investigator of the Marine Resiliency Study. This is one of two recent studies by San Diego researchers with the U.S. Department of Veterans Affairs that chip away at questions surrounding the signature wounds of the Iraq and Afghanistan war generation PTSD and traumatic brain injury. Moderate or severe brain trauma raised PTSD symptom scores by 71 percent, according to research findings. Mild brain trauma increased PTSD scores by 23 percent. Other factors, such as the heat of combat … Continue reading →

Posted in Brain Injury Treatment | Comments Off on New research: Blast injury predicts PTSD

Warehouse worker jailed for crash which left baby girl with brain injury

Posted: Published on February 5th, 2014

Gendrihs Kuplovs-Okinskis jailed for crash which left baby with brain injury 6:39pm Tuesday 4th February 2014 in News A WAREHOUSE worker who crashed a lorry into a familys car and left a baby girl with a brain injury has been jailed. Gendrihs Kuplovs-Okinskis claimed his bosses told him to drive the bread delivery lorry or lose his job at Peacock Foods in Halstead. He had veered into the path of oncoming traffic in Coggeshall Road in Earls Colne and smashed into a Vauxhall Zafira car. The crash on September 6 2012 at 7pm left the lorry on its side and the car, being driven by off-duty police officer David Moon, was destroyed. Mr Moon, who has advanced driving experience, was left with a broken rib and his daughter Ella suffered cuts and bruises. Her younger sister Maisie, aged 15 months at the time, suffered serious head injuries and had to be flown to Addenbrookes Hospital in Cambridge for life-saving treatment. Read the full story in tomorrow's Gazette. Read this article: Warehouse worker jailed for crash which left baby girl with brain injury … Continue reading →

Posted in Brain Injury Treatment | Comments Off on Warehouse worker jailed for crash which left baby girl with brain injury

Life-changing MS treatment shows promise

Posted: Published on February 5th, 2014

Australian scientists are showing promising results with a new treatment for advanced multiple sclerosis (MS). It's early days, but it has changed the life of Dr Gary Allen, a 43-year-old academic with secondary progressive MS who agreed to be a guinea pig. He was given six weeks of treatment, which resulted in a sustained boost of energy, reduced pain and increased productivity at work. "It's impossible to overstate the improvements," said Dr Allen. The study on the treatment is a high point in the career of Professor Michael Pender, who has been researching MS for 33 years. In 2003 he proposed a new theory that people with MS have impaired immunity to Epstein-Barr virus (EBV). There is a growing body of evidence to support his view that this allows the virus to accumulate in the brain and cause MS. EBV is a well known as a cause of glandular fever. The new treatment boosts the body's ability to fight the virus, said Prof Pender, of The University of Queensland. "EBV gets out of control in the brain of MS patients. See original here: Life-changing MS treatment shows promise … Continue reading →

Posted in MS Treatment | Comments Off on Life-changing MS treatment shows promise

Milwaukee mother denied treatment that could reverse her MS

Posted: Published on February 5th, 2014

MILWAUKEE-Lakesha Johnson wants to be a good wife and mother. But her multiple sclerosis keeps getting in the way. "I have blurred vision. I see four of you now," the 33 year old recently told CBS 58's Michele McCormack in an exclusive interview from her Milwaukee home. "I also have this blind spot in the middle which is really weird and my right leg goes completely numb. I'm dragging it.I can't feel it at all." She was diagnosed in 2007. Traditional drugs have failed her. She undergone 22 sessions of chemotherapy with steroids. The symptoms keep coming on. There was new hope recently when her doctor told her she was an excellent candidate for a stem cell transplant study at Northwestern Hospital which uses an MS patient's own stem cells. "Their neurological disability reverses." the study's founder Dr. Richard Burt told CBS 58 News during a recent tour of his lab in Chicago. "Even though they're on no therapy after this treatment for MS," he explained, "they improve neurologically at six months. They're better at one year than six months and the maximum improvement is two years after the procedure with reversal of what had been neurological deficits." Dr. Burt … Continue reading →

Posted in MS Treatment | Comments Off on Milwaukee mother denied treatment that could reverse her MS

Edison Pharmaceuticals' EPI-743 Granted FDA Orphan Drug Status for Friedreich's Ataxia

Posted: Published on February 5th, 2014

Downingtown, PA (PRWEB) February 04, 2014 Edison Pharmaceuticals today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug status to vatiquinone (EPI-743) for the treatment of Friedreichs ataxia (http://www.prnewswire.com/news-releases/fda-grants-edison-pharmaceuticals-epi-743-orphan-status-for-friedreichs-ataxia-243439351.html). Orphan status brings additional momentum and acceleration to the clinical development of EPI-743 now underway at three sites in the Friedreich's Ataxia Research Alliance (FARA) Collaborative Clinical Research Network. The FDA's Orphan Drug Designation program was established by the Orphan Drug Act of 1983 to provide further incentives for the biopharmaceuticals industry to develop therapies for rare diseases. The FDA can grant this status to a drug that is being developed specifically to treat a rare condition and that has shown potential benefit for that disorder. Among the incentives is an extension of the period of market exclusivity, partial reimbursement of development costs via tax benefits, waiver of prescription drug user fees, and expedited review of applications for drug approval (within six months of application). The FDAs granting of orphan designation underscores the promise that EPI-743 has for the treatment of Friedreichs ataxia, stated Guy Miller, MD, PhD, Chairman & CEO, Edison Pharmaceuticals. The phase 2b clinical trial of EPI-743 in Friedreich's ataxia began in early 2013 … Continue reading →

Comments Off on Edison Pharmaceuticals' EPI-743 Granted FDA Orphan Drug Status for Friedreich's Ataxia

Stem Cell Discovery From Blood and Acid – Video

Posted: Published on February 5th, 2014

Stem Cell Discovery From Blood and Acid Stem Cells have been created in a laboratory by dipping blood cells into acid. The discovery has been made by Japanese scientist, Dr. Haruko Obokata, and has... By: TheLipTV … Continue reading →

Posted in Stem Cell Research | Comments Off on Stem Cell Discovery From Blood and Acid – Video

Cleveland Clinic, CWRU researchers harvest stem cells from …

Posted: Published on February 5th, 2014

What do you think about using discarded bone as a source of stem cells? Let us know in the comments below. CLEVELAND, Ohio -- To make room for the metal and plastic of a hip replacement, surgeons have to remove and throw away tissue and bone. Now a team of researchers, including an orthopedic surgeon at the Cleveland Clinic and a former PhD candidate at Case Western Reserve University, has found what might prove to be a rich new source of adult stem cells amidst those normally discarded parts of the old joint. These stem cells, which differ from those that come from the bone marrow, are great at building new tissue, including bone and cartilage, said Dr. Ulf Knothe, orthopedic surgeon at the Clinic and the leading clinical scientist on the study, which was published online last week in STEM CELLS Translational Medicine. The cells come from the periosteum, or the soft tissue adhering to the surface of the bone like a skin, he said. They are called, unsurprisingly, periosteum-derived stem cells, or PDCs. Knothes research team had shown in lab tests in the past that PDCs can regenerate bone and cartilage, but the cells are difficult to access. … Continue reading →

Posted in Stem Cell Research | Comments Off on Cleveland Clinic, CWRU researchers harvest stem cells from …

Joseph Purita, M.D. of Global Stem Cells Group, Inc. Featured Speaker at 21st Annual World Congress on Anti-Aging …

Posted: Published on February 5th, 2014

Las Vegas, NV (PRWEB) February 05, 2014 Global Stem Cells Group, Inc. and affiliate Stem Cell Training, Inc. were represented by Josepth Purita, M.D. at the 21st Annual World Congress on Anti-Aging, Regenerative and Aesthetic Medicine in Las Vegas, Dec. 15, 2013. Purita, a lead trainer for Stem Cell Training, Inc. and a pioneer in the use of stem cell therapies in orthopedics, addressed more than 5,000 conference attendees with his presentation titled, Cutting Edge Concepts for the Regenerative Medicine Physician in the Use of Stem Cell & PRP Injections. The record number of attendees gathered from around the world at the Venetian/Palazzo Resort in Las Vegas for three days to attend the prestigious conference hosted by the American Academy of Anti-aging Medicine. The conference featured physicians and medical personnel who practice and manage stem cell technology, certification, and pellet therapy to discuss brain health and offer case studies. Workshops on personalized lifestyle medicine and aesthetic medicine were also held. Purita was joined by an illustrious group of speakers including: Author Judith Reichman, M.D., womens health care expert and specialist in gynecology, infertility and menopause; Travis Stork, M.D., ER physician and host of the Emmy Award-winning talk show, The Doctors; … Continue reading →

Comments Off on Joseph Purita, M.D. of Global Stem Cells Group, Inc. Featured Speaker at 21st Annual World Congress on Anti-Aging …

In Vitro Innovation: Testing Nanomedicine With Blood Cells On A Microchip

Posted: Published on February 5th, 2014

Contact Information Available for logged-in reporters only Newswise Designing nanomedicine to combat diseases is a hot area of scientific research, primarily for treating cancer, but very little is known in the context of atherosclerotic disease. Scientists have engineered a microchip coated with blood vessel cells to learn more about the conditions under which nanoparticles accumulate in the plaque-filled arteries of patients with atherosclerosis, the underlying cause of myocardial infarction and stroke. In the research, microchips were coated with a thin layer of endothelial cells, which make up the interior surface of blood vessels. In healthy blood vessels, endothelial cells act as a barrier to keep foreign objects out of the bloodstream. But at sites prone to atherosclerosis, the endothelial barrier breaks down, allowing things to move in and out of arteries that shouldnt. In a new study, nanoparticles were able to cross the endothelial cell layer on the microchip under conditions that mimic the permeable layer in atherosclerosis. The results on the microfluidic device correlated well with nanoparticle accumulation in the arteries of an animal model with atherosclerosis, demonstrating the devices capability to help screen nanoparticles and optimize their design. Its a simple model a microchip, not cell culture dish … Continue reading →

Comments Off on In Vitro Innovation: Testing Nanomedicine With Blood Cells On A Microchip

Page 4,637«..1020..4,6364,6374,6384,639..4,6504,660..»